Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01304108 · ClinicalTrials.gov registry record · Phase 4
Improving Venous Thromboembolism Prophylaxis
A Phase 4 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 3,000
- Enrollment target
NCT01304108: Completed Phase 4 study, sponsored by Mayo Clinic.
NCT01304108 is a Phase 4 study that has completed, run by Mayo Clinic. The registered enrollment target is 3,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01304108, a Phase 4 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 3,000 participants
- Enrollment target
Study Summary
Preventing the formation of blood clots in the veins so they do not injure leg veins or travel to the lungs, also called venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including The investigators own. Two prior VTE-P improvement projects were completed at Mayo Clinic hospitals, one in the Department of Medicine, and the other in selected divisions of the Department of Surgery. Both projects resulted in marked improvement in the percentage of patients receiving appropriate VTE-P. This project seeks to utilize the lessons learned from these two pilots along with known best practices for \"spreading\" to deploy methods that enhance VTE-P to the entire hospitalized population. The investigators seek appropriate VTE-P rates exceeding 95%.
Interventions
- OTHER Usual Care
- OTHER VTE-P Tollgate
- OTHER BLAZE Pop up
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,000 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01304108
The ClinicalTrials.gov registry entry for NCT01304108 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 3,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT01304108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01304108 about?
NCT01304108 is a clinical study titled "Improving Venous Thromboembolism Prophylaxis". Preventing the formation of blood clots in the veins so they do not injure leg veins or travel to the lungs, also called venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including The investigators own. ...
What is the current status of trial NCT01304108?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 3,000 participants. The study started on 2009-01. Estimated completion is 2010-05.
What interventions are being tested in trial NCT01304108?
The interventions under investigation include: Usual Care (OTHER), VTE-P Tollgate (OTHER), BLAZE Pop up (OTHER).
Who is sponsoring clinical trial NCT01304108?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.